July 7, 2022 — Thank you to all our amazing supporters who helped us go above and beyond our $100,000 Stop Cancer Furever gift match from Petco Love and Blue Buffalo. Your generosity goes a long way toward supporting cancer research to improve the health and well-being of dogs, cats, horses and wildlife everywhere.
In just the last year, thanks to your support, we’ve funded life-saving cancer research impacting animals in our homes and around the world. Our funded researchers are pushing the boundaries of cancer detection, treatment and prevention. From the development of new blood tests for early detection of lymphoma in dogs to promising new treatments for oral cancer in cats, your gifts make a real difference.
And you are helping us do so much more.
Hemangiosarcoma is one of the leading causes of cancer deaths in dogs and we have invested more than $3 million to better understand this devastating disease, explore treatment options and develop tools for earlier diagnosis.
Our Golden Retriever Lifetime Study is investigating nutritional, environmental, lifestyle and genetic risk factors for cancers like hemangiosarcoma, osteosarcoma, lymphoma and mast cell tumors in dogs.
Recently, we shared the story of participant owners Julie and Marc Cuenod, who lost their beloved Tate, Angel Hero #2460, last summer to stomach cancer. Julie and Marc’s other dog, Ellie, Hero #2349, also struggled with cancer. Ellie’s her mast cell tumors were removed and she’s doing well. Despite the challenges of the last 18 months, the Cuenods take comfort in knowing that scientific learnings from Ellie and Tate’s experiences could help other dogs in the future.
We’ve been funding equine cancer research for over two decades, including squamous cell carcinoma, sarcoid tumors and melanoma. One research team developed a screening test for ocular squamous cell carcinoma in Haflinger horses, a high-risk breed for the disease, and another research team discovered that a commercially available canine melanoma vaccine can help treat this cancer in horses.
Our researchers are hard at work trying to understand more about a particularly unique form of cancer impacting Tasmanian devils. Devil facial tumor disease (DFTD) is a transmissible cancer passed from one devil to another through biting, a common behavior that takes place during feeding and mating. Development of a vaccine as a possible solution is in the works and we will continue to fund studies to address this critical health threat.
You’re helping create a better world for animals everywhere. Together, we’re working to Stop Cancer Furever. Thank you!
